Raymond James Starts Tarsus Pharmaceuticals (TARS) at Strong Buy, $39 PT
Tweet Send to a Friend
(Updated - November 10, 2020 7:16 AM EST)(updated to add analyst comments)Raymond James analyst Dane Leone initiates coverage on Tarsus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
